KYGEVVI (doxecitine and doxribtimine)

Kygevvi is a combination of doxecitine and doxribtimine, both pyrimidine nucleosides, used for the treatment of thymidine kinase 2 deficiency (TK2d) in adults and pediatric patients with an age of symptom onset on or before 12 years.

Recommended Dosage:
The recommended dosage of Kygevvi is based on the patient’s weight. Titrate to the next dosage level based on tolerability after a minimum of 2 weeks at the current dosage level.

• Starting Dosage: 260 mg/kg/day (consisting of 130 mg doxecitine and 130 mg doxribtimine)
• Intermediate Dosage: 520 mg/kg/day (consisting of 260 mg doxecitine and 260 mg doxribtimine)
• Maintenance Dosage: 800 mg/kg/day (consisting of 400 mg doxecitine and 400 mg doxribtimine)

Administer this therapeutic drug orally in 3 equally divided doses approximately 6 hours apart (plus or minus 2 hours) with food.

In case a dose is missed, take the missed dose as quickly as you can, but do not take it within 2 hours of the next scheduled dose. In that case, skip the missed dose and return to your regular schedule. Do not take a double dose to compensate for a missed dose.

• Treatment with Kygevvi may be responsible for increased liver enzymes. Check liver tests before initiating and throughout treatment. Watch for nausea, tiredness, dark urine, or yellow skin or eyes. Stop treatment and contact a clinician if liver values rise significantly or symptoms occur promptly.
• This therapeutic drug can cause nausea, stomach upset, diarrhea, or vomiting. Take it as directed and maintain fluids. Let your doctor know if symptoms are serious, persistent, or cause dehydration, weight loss, or weakness, as dose changes or interruption may be required temporarily.
• Kygevvi may harm an unborn baby. Avoid using it during pregnancy. Confirm pregnancy status before starting and use effective contraception during treatment. If pregnancy occurs, stop treatment and contact your clinician for risks, benefits, and alternative options immediately together.
• It is unknown whether Kygevvi passes into breast milk. Because of possible serious effects in infants, breastfeeding is not recommended during treatment and for a period after the last dose. Discuss feeding choices and timing with your healthcare provider carefully.
• The safety and effectiveness of this combination medicine in children need careful monitoring. Use it only under the supervision of a specialist. Follow prescribed dosing exactly and don’t miss regular checkups. Report any unusual signs and symptoms, growth concerns, or side effects immediately to ensure safe, appropriate treatment for children.

What documents are required to import KYGEVVI to India?

KYGEVVI (doxecitine and doxribtimine) oral solution can be imported by patients or government hospitals in the name of the patients only.

• The following documentation is required to import the product:
• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order get confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable

Is KYGEVVI available in India?

KYGEVVI (doxecitine and doxribtimine oral solution) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator, providing input

• On the availability of Kygevvi in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
• Kygevvi price in India.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

KYGEVVI can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of KYGEVVI (prescription medicines) to all locations in the world and India after fulfilling the legal requirements (if applicable).

Please contact +91-9810469557 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Kygevvi cost in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source KYGEVVI (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Kygevvi®?

Doxecitine and Doxribtimine is the Generic Name for the trade name drug Kygevvi®.

What is the Manufacturer’s Name of Kygevvi®?

Kygevvi® is manufactured by UCB, Inc.

Is Kygevvi approved by the FDA?

Yes. Kygevvi is approved by the FDA. date of first approval: November 3, 2025.

What is the dosage and form of Kygevvi® supplied?

Kygevvi is supplied as powder for oral solution: 2 g doxecitine and 2 g doxribtimine.

What are the most common side effects of Kygevvi® oral solution?

The most commonly reported side effects of Kygevvi® are diarrhea, abdominal pain (including abdominal pain upper), vomiting, alanine aminotransferase increased (ALT), and aspartate aminotransferase increased (AST).

How does Kygevvi Import in India work?

Kygevvi Import in India is possible through the Named Patient Program. This means the medicine can be imported for a specific patient with a valid doctor’s prescription. Indian Pharma Network helps manage the complete process, including approvals and delivery, making sure the medicine reaches the patient safely and legally.

How much does Kygevvi® oral solution cost in India?

Kygevvi® is not yet approved in India. However, patients in India can legally access it through the provision called the Named Patient Program (NPP). Kygevvi prices may fluctuate over time because of market dynamics and regulatory changes. For the most transparent and latest Kygevvi cost in India, please call/WhatsApp +91 98104 69557 or send an email to info@indianpharmanetwork.in.

Can Kygevvi® oral solution be available in SAARC countries?

Apart from Gulf countries, Kygevvi® can be accessed through import provisions like the Named Patient Program (NPP) in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Kygevvi® oral solution in these countries. We help provide legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Kygevvi® oral solution online in India?

Yes, one can buy Kygevvi in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not yet registered or available in their country. We can help facilitate the supply of Kygevvi® oral solution through legal channels.

What are the storage conditions of Kygevvi® oral solution?

Store reconstituted solution at controlled room temperature between 20-25°C (68°F to 77°F) or in the refrigerator between 2-8°C (36°F to 46°F).